- Home
- ECOR vs CRT Comparison
ECOR vs CRT Comparison
Compare ECOR & CRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ECOR
- CRT
- Stock Information
- Founded
- ECOR 2005
- CRT 1991
- Country
- ECOR United States
- CRT United States
- Employees
- ECOR N/A
- CRT N/A
- Industry
- ECOR Biotechnology: Electromedical & Electrotherapeutic Apparatus
- CRT Oil & Gas Production
- Sector
- ECOR Health Care
- CRT Energy
- Exchange
- ECOR Nasdaq
- CRT Nasdaq
- Market Cap
- ECOR 40.1M
- CRT 65.1M
- IPO Year
- ECOR 2018
- CRT 1992
- Fundamental
- Price
- ECOR $5.19
- CRT $10.09
- Analyst Decision
- ECOR Strong Buy
- CRT
- Analyst Count
- ECOR 2
- CRT 0
- Target Price
- ECOR $25.50
- CRT N/A
- AVG Volume (30 Days)
- ECOR 122.7K
- CRT 24.0K
- Earning Date
- ECOR 05-07-2025
- CRT 01-01-0001
- Dividend Yield
- ECOR N/A
- CRT 8.80%
- EPS Growth
- ECOR N/A
- CRT N/A
- EPS
- ECOR N/A
- CRT 0.95
- Revenue
- ECOR $25,182,000.00
- CRT $6,623,430.00
- Revenue This Year
- ECOR $32.20
- CRT N/A
- Revenue Next Year
- ECOR $46.27
- CRT N/A
- P/E Ratio
- ECOR N/A
- CRT $10.63
- Revenue Growth
- ECOR 57.09
- CRT N/A
- 52 Week Low
- ECOR $5.02
- CRT $8.88
- 52 Week High
- ECOR $19.49
- CRT $14.40
- Technical
- Relative Strength Index (RSI)
- ECOR 31.29
- CRT 43.19
- Support Level
- ECOR $6.01
- CRT $9.91
- Resistance Level
- ECOR $7.14
- CRT $10.46
- Average True Range (ATR)
- ECOR 0.80
- CRT 0.37
- MACD
- ECOR 0.07
- CRT -0.01
- Stochastic Oscillator
- ECOR 3.99
- CRT 20.79
About ECOR electroCore Inc.
electroCore Inc is a commercial stage bioelectronic medicine company with a platform for non-invasive vagus nerve stimulation therapy initially focused on neurology. The company's product gammaCore is Food and Drug Administration cleared in the United States for adjunctive use for the preventive treatment of cluster headache in adult patients, the acute treatment of pain associated with episodic cluster headache in adult patients, the acute treatment of pain associated with migraine headache in adult patients, and the prevention of migraine in adult patients, The use of gammaCore by adolescent patients and Treatment of hemicrania continua and paroxysmal hemicrania in adult patients.
About CRT Cross Timbers Royalty Trust
Cross Timbers Royalty Trust is a United States-based trust. The net profits interests are derived from producing royalty, overriding royalty interests, and working interest properties. The underlying properties of the trust include producing properties in Texas, Oklahoma, and New Mexico.